After Johnson & Johnson executed a divisional merger and filed for bankruptcy in October 2021, the company received protection from litigation related to its talcum powder lawsuits. Recently, the federal judge overseeing talcum litigation in New Jersey ruled that a bankruptcy judge must now determine how to proceed with the company’s current shield from lawsuits.
Lawyers connected to the Johnson & Johnson (J&J) talcum-based baby powder lawsuits are calling the company’s filing for Chapter 11 bankruptcy a “masquerade,” according to Law360. Attorneys are criticizing J&J for its transparent attempt to shield itself from liability claims. The move has several potential consequences for plaintiffs in these lawsuits, including a delay in litigation.
U.S. Bankruptcy Judge Craig Whitley in Charlotte, North Carolina ordered that tens of thousands of lawsuits against Johnson & Johnson be moved to New Jersey, according to a November 10, 2021 report from Reuters. Judge Whitley explained that his decision hinged on two factors: the fact that Johnson & Johnson is headquartered in New Jersey and the fact that a substantial amount of the country’s talc litigation is happening there.
Plaintiffs in talc cancer lawsuits against Johnson & Johnson have had a white-knuckle time of it after hearing the company’s plans to file bankruptcy. If you are among the worriers, you should know that your legal action remains alive and well. However, J&J’s maneuverings could change some aspects of how your case is handled.
The United States Supreme Court (SCOTUS) has rejected Johnson & Johnson’s (J&J) challenge of a $2.1 billion judgment awarded to 20 women who brought product liability claims against the company for its talc-based powders.
As the number of talc powder lawsuits against Johnson & Johnson continues to rise, the multinational corporation has reserved $3.9 billion for litigation expenses and settlements, reports Business Insider. The planned reserve represents a marked increase from the $400 million that Johnson & Johnson (J&J) had earmarked for such expenses in 2019.
Johnson & Johnson is the defendant in more than 20,000 lawsuits that allege the company’s talcum-based Johnson’s Baby Powder and Shower-to-Shower caused plaintiffs to develop mesothelioma and ovarian cancer. In one such case, Olson v. Brenntag N. Am., Inc., plaintiffs Donna Olson and Robert Olson thought they had won big in their suit.
After four years of litigation between plaintiffs and Johnson & Johnson, the multinational corporation agreed to the first set of major settlements. The agreement to pay $100 million will resolve more than 1,000 lawsuits in which plaintiffs allege that the talc in Johnson & Johnson’s signature baby powder causes cancer, according to a Bloomberg report. This settlement marks the first to come from almost 20,000 lawsuits.
Since the early 1900’s Johnson & Johnson has proudly advertised its Johnson’s Baby Powder as “Best for the Baby—Best for You.” Although the massive, multinational company continues to stand by this message, it has finally conceded to others who disagree by discontinuing sales of its talc-based baby powder in North America.
The coronavirus outbreak has touched virtually every aspect of our lives, including our court system. On March 18, a New Jersey state court declared it was delaying proceedings in a case against American International Industries, the parent company for talc-product manufacturer Clubman.
In the lawsuit, two hairdressers, Margaret Lashley and Dwayne Johnson, seek justice for their exposure to asbestos in Clubman brand’s cosmetic talc products they used in a barbershop. The plaintiffs claim that this exposure caused their fatal cancer.